Effects of Motion and Tissue Weighting on PET Myocardial Blood Flow Estimates
|
|
- Avis Byrd
- 6 years ago
- Views:
Transcription
1 Effects of Motion and Tissue Weighting on PET Myocardial Blood Flow Estimates Benjamin C. Lee 1, Jonathan B. Moody 1, Venkatesh L. Murthy 2, James R. Corbett 2, Edward P. Ficaro 2 1 INVIA Medical Imaging Solutions, Ann Arbor, MI, 2 University of Michigan Health System, Ann Arbor, MI Disclosures: BC Lee, J Moody, Employee: INVIA; VL Murthy, Stock Shareholder: GE, Grant: INVIA; JR Corbett, EP Ficaro, Owners: INVIA.
2 Introduction Background Relative PET perfusion imaging provides suboptimal clinical information of diffuse or multistenosis coronary artery disease (CAD) Dynamic 82 Rb PET measurements of myocardial blood flow (MBF) and coronary flow reserve (CFR) may improve those prognostic and diagnostic yields Respiratory motion may have an effect on the estimates of MBF and CFR
3 Introduction Background (cont d) Dataset with motion with blood pool spillover into myocardium Severe Motion Uncorrected Manual Motion Corrected
4 Introduction Background (cont d) Time activity curves (TAC) affected by motion Severe Motion TAC Manual Motion Corrected TAC 4
5 Activity (kbq/ml) Introduction Background (cont d) Weighting tissue data may reduce motion effects LV Blood LAD Tissue Tissue Weight Time (sec)
6 Introduction Objectives Identify prevalence of respiratory motion in dynamic PET myocardial perfusion images Study respiratory motion effects on MBF and CFR estimates Manual motion correction is labor intensive therefore investigate effect of preferentially increasing weight in tissue-phase frames to offset respiratory motion blood-phase frames
7 Methods Data Acquisition 53 sequential patients referred for dynamic stress/rest 82 Rb PET imaging Acquired in 3-D list mode on Siemens Biograph mct serial dynamic frames over 6.7 minutes 16 x 5sec, 6 x 10sec, 3 x 20sec, 4 x 30sec, 1 x 80sec Reconstructed using 3D-OSEM with PSF Attenuation corrected, 3 iterations with 24 subsets, no post-filtering 7
8 Methods Motion Analysis Visually assessed motion by maximum shift btwn. Blood pool in first 2 min. (first 20 frames) LV surface generated from post 2 min. as reference Categorized respiratory motion as: Minimal motion (sub-pixel shift) Moderate motion (1/2 wall thickness shift) Severe motion (full wall thickness shift) Datasets with moderate or severe respiratory motion were manually corrected for comparison 8
9 Methods Kinetic Analysis ROI method sampled left ventricular (LV) blood pool and tissue time activity curves (TAC) Kinetic fitting using Corridor4DM software (INVIA) 1-tissue compartment with Lortie flow model Weighting models No weighting Weighting using frame duration, decay correction factor, and activity concentration Evaluated mean MBF, CFR, and relative changes 9
10 Results Prevalence of Motion Motion was observed in 85% of the datasets with majority 55% of those with bloodpool in region Motion by Severity Motion* by Region Severe Moderate Minimal LAD LCX 100% 75% 50% 25% 17% 13% 15% 40% 53% 46% 43% 34% 39% 85% 100% 75% 50% 25% 14% 18% 68% 22% 18% 36% 42% 27% 55% 0% Stress Rest All 0% Stress Rest All *moderate and severe only
11 Results Change Bias, LOA MBF and CFR Effects from Motion Compared to motioncorrected, mean MBF and CFR changed < 5%, except for stress MBF with severe motion of 6% Mean stress MBF with severe motion had mean bias of 0.1* and 95% limits of agreement (LOA)** of 0.7* 10% 5% 0% Moderate Motion Severe Motion * p < 0.05 * * * Stress MBF Rest MBF CFR Stress MBF Rest MBF CFR *(ml/min/g), **95% LOA=1.96 Stdev -1.0
12 Results Regional Change Regional Bias, LOA Regional Stress MBF Effects from Motion Mean stress MBF changes were less than 6% except for with severe motion of 20% with severe motion had mean stress MBF bias of 0.5* and 95% limits of agreement of 1.6* *(ml/min/g) 25% 20% 15% 10% 5% 0% Moderate Motion * p < 0.05 * LAD Stress MBF LAD Stress MBF Severe Motion * LCX Stress MBF LCX Stress MBF * Stress MBF Stress MBF
13 Results Regional Change Regional Bias, LOA Regional CFR Effects from Motion Mean CFR changes were less than 4% except for with severe motion of 18% with severe motion had mean CFR bias of 0.4 and 95% limits of agreement of % 15% 10% 5% 0% -5% Moderate Motion Severe Motion * p < 0.05 LAD CFR LCX CFR CFR LAD CFR LCX CFR CFR * *
14 Results Stress MBF Change Stress MBF Bias, LOA Tissue Weighting Effects on Stress MBF Tissue weighting (nonmotion corrected) did not reduce mean stress MBF bias Especially for with severe motion, change was only -1.4% point 95% limits of agreement did not decrease significantly 25% 20% 15% 10% 5% 0% * p < 0.05 No Weight Weight
15 Results CFR Change CFR Bias, LOA Tissue Weighting Effects on CFR Tissue weighting (nonmotion corrected) did not reduce mean CFR bias with severe motion increased with change of just 1.4% point 25% 20% 15% 10% 5% 0% 3.0 * p < 0.05 No Weight Weight 95% limits of agreement did not decrease significantly
16 Limitations Manual Motion Correction Possible miscategorization of severe, moderate, and minimal respiratory motion No Tissue Phase (>2min) Motion Correction Reference LV surfaces generated from tissue phase Longer frame durations are motion averaged Lower count statistics in later frames
17 Conclusions Respiratory motion is common (up to 85%) in the blood pool phase due to fast kinetics of the tracer and the short time sampling. Increases in MBF and CFR estimates were observed in studies with moderate and severe respiratory motion, and substantially in the. Tissue weighting did not have desired result in greatly reducing respiratory motion induced bias. Motion correction is necessary to reduce bias in MBF and CFR.
18 Appendix
19 Activity (kbq/ml) Appendix: Frame Duration Weighting Weighting tissue data with frame duration only may reduce respiratory motion effects further LV Blood LAD Tissue Tissue Weight Duration Weight Time (sec)
20 Stress MBF Change Appendix: Frame Duration Weighting Tissue Weighting Effects on Stress MBF Compared to no weighting, stress MBF with frame duration only weighting changed -2% points, except for with severe motion of -0.8% point No Weight Weight Duration Weight 25% 20% * p < 0.05 * 15% 10% 5% * 0% -5% (Minimal) (Minimal)
21 Appendix: Frame Duration Weighting CFR Change Tissue Weighting Effects on CFR Compared to no weighting, CFR with frame duration only weighting changed 1% point, except for with moderate and severe motion of 3% and 5% points respect. 25% 20% 15% * p < 0.05 No Weight Weight Duration Weight * 10% 5% * * 0% -5% (Minimal) (Minimal)
Precision and accuracy of clinical quantification of myocardial blood flow by dynamic PET: a technical perspective
Precision and accuracy of clinical quantification of myocardial blood flow by dynamic PET: a technical perspective Jonathan B. Moody, PhD (1), Benjamin C. Lee, PhD (1), James R. Corbett, MD (2,3), Edward
More informationConflict of Interest Disclosure
Comparative Advantages of PET Over SPECT: Is PET Really Better? Timothy M. Bateman M.D. Co-Director, Cardiovascular Radiologic Imaging Mid America Heart Institute Professor of Medicine University of Missouri-Kansas
More informationNormal LV Ejection Fraction Limits Using 4D-MSPECT: Comparisons of Gated Perfusion and Gated Blood Pool SPECT Data with Planar Blood Pool
Normal LV Ejection Fraction Limits Using 4D-MSPECT: Comparisons of Gated Perfusion and Gated Blood Pool SPECT Data with Planar Blood Pool EP Ficaro, JN Kritzman, JR Corbett University of Michigan Health
More informationMyocardial Blood Flow from Dynamic PET using Independent Component Analysis
2012 IEEE Nuclear Science Symposium and Medical Imaging Conference Record (NSSIMIC) M07-4 Myocardial Blood Flow from Dynamic PET using Independent Component Analysis Alexander Karpikov, Hemant Tagare,
More informationComparison between 1-compartmental and 2-compartmental model in calculation of myocardium blood flow in 82 Rb PET imaging
ORIGINAL RESEARCH Comparison between 1-compartmental and 2-compartmental model in calculation of myocardium blood flow in 82 Rb PET imaging Karin Knesaurek, Josef Machac Division of Nuclear Medicine, the
More informationCalculating Coronary Flow Reserve with CZT SPECT Fundamentals and Applications. White Paper
Calculating Coronary Flow Reserve with CZT SPECT Fundamentals and Applications White Paper Introduction For over half a century, detection of coronary artery stenosis and evaluation of their physiologic
More informationTypical PET Image. Elevated uptake of FDG (related to metabolism) Lung cancer example: But where exactly is it located?
Typical PET Image Elevated uptake of FDG (related to metabolism) Lung cancer example: But where exactly is it located? PET/CT Oncology Imaging Anatometabolic fusion images are useful in the management
More informationTW Hamilton, EP Ficaro, TA Mitchell, JN Kritzman, JR Corbett University of Michigan Health System, Ann Arbor, MI
Accuracy and Variability of of 3D-MSPECT for Estimating the Left Ventricular Ejection Fraction as as a Function of of Gating Frames and Reconstruction Filters TW Hamilton, EP Ficaro, TA Mitchell, JN Kritzman,
More informationPET is currently the accepted gold standard in noninvasive
CT Attenuation Correction for Myocardial Perfusion Quantification Using a PET/CT Hybrid Scanner Pascal Koepfli, MD 1 ; Thomas F. Hany, MD 2 ; Christophe A. Wyss, MD 1 ; Mehdi Namdar, MD 1 ; Cyrill Burger,
More informationPearls & Pitfalls in nuclear cardiology
Pearls & Pitfalls in nuclear cardiology Maythinee Chantadisai, MD., NM physician Division of Nuclear Medicine, Department of radiology, KCMH Principle of myocardial perfusion imaging (MPI) Radiotracer
More informationMyocardial Perfusion: Positron Emission Tomography
Myocardial Perfusion: Positron Emission Tomography TH. Schindler, MD University Hospitals of Geneva, Cardiovascular Center, Geneva, Switzerland ESC 2010 Stockholm Personal Disclosure Research Grant support
More informationNuclear Cardiology Cardiac Myocardial Perfusion with 82 Rb. Dominique Delbeke, MD, PhD Vanderbilt University Medical Center Nashville, TN
Nuclear Cardiology Cardiac Myocardial Perfusion with 82 Rb Dominique Delbeke, MD, PhD Vanderbilt University Medical Center Nashville, TN VUMC PET/CT conference 2009 82 Rb Cardiac Perfusion PET 82 Rb is
More informationRADIOTRACERS FOR MYOCARDIAL PERFUSION IMAGING
RADIOTRACERS FOR MYOCARDIAL PERFUSION IMAGING RAYMOND TAILLEFER, M.D. FRCP(c), ABNM DIRECTOR, DEPARTMENT OF NUCLEAR MEDICINE HOPITAL ST-JEAN-SUR-RICHELIEU Disclosures to Report: Grant Research Support:
More informationPreview of Presentation
Preview of Presentation Discuss Healthcare Environment Clinical Implementation of Technical Innovations SNMMI/ASNC Joint Statement on Rb-82 Cardiac PET Imaging Protocol Principles of Rb-82 Cardiac Imaging
More informationSPECT or PET for Cardiovascular Screening in High-Risk Patients
SPECT or PET for Cardiovascular Screening in High-Risk Patients Paeng, Jin Chul MD PhD Department of Nuclear Medicine Seoul National University Hospital Contents Recent Development in SPECT and PET Technology
More information海外研究留学報告 福島賢慈 東京女子医科大学 画像診断 核医学部 核医学地方会 2011 Jan
2011 Jan Maryland state (MD), USA Maryland state (MD), USA Baltimore city, MD Baltimore city, MD Myocardial Perfusion PET tracers PET Tracers Half life Production First Pass Extraction Kinetic Properties
More informationAnimals. Male C57Bl/6 mice (n=27) were obtained from Charles River (Sulzfeld, Germany) and
Supplemental Methods Animals. Male C57Bl/6 mice (n=27) were obtained from Charles River (Sulzfeld, Germany) and housed in groups of 5-10 in individually ventilated BCU cages within a temperature controlled
More informationZahid Rahman Khan, MD(USA), MS Diplomate American Board of Nuclear Medicine Consultant t Nuclear Medicine
Zahid Rahman Khan, MD(USA), MS Diplomate American Board of Nuclear Medicine Consultant t Nuclear Medicine i North West Armed Forces Hospital Tabuk, KSA. 1 Introduction Hibernation: Term coined by Rahimtoola
More informationMyocardial blood flow PET evaluation and quantification. Dr. Erick Alexánderson. Rosas
Myocardial blood flow PET evaluation and quantification Dr. Erick Alexánderson Rosas Clinical case 62 year old female patient with a history of DM2 and chronic systemic hypertension She complains of progressive
More informationDetection Of Functional Significance of Coronary Stenoses Using Dynamic. Values Of Myocardial Blood Flow And Coronary Flow Reserve
The 2nd International Symposium on Physics, Engineering and Technologies for Biomedicine Volume 2018 Conference Paper Detection Of Functional Significance of Coronary Stenoses Using Dynamic 13 N-Ammonia
More informationQualitative and Quantitative Assessment of Perfusion
APCDE 2011 Qualitative and Quantitative Assessment of Perfusion Hyun Ju Yoon Chonnam National University Hospital Gwangju, Korea ISCHEMIC CASCADE Blood flow mismatch Perfusion defects on nuclear imaging,
More informationOTHER NON-CARDIAC USES OF Tc-99m CARDIAC AGENTS Tc-99m Sestamibi for parathyroid imaging, breast tumor imaging, and imaging of other malignant tumors.
DEFINITION OF CARDIAC RADIOPHARMACEUTICAL: A radioactive drug which, when administered for purpose of diagnosis of heart disease, typically elicits no physiological response from the patient. Even though
More informationCT Myocardial Perfusion
1 CT Myocardial Perfusion Ting-Yim Lee, PhD, FCCPM, FCOMP Aaron So, PhD, FSCCT Gerald Wisenberg, MD, FRCPC Ali Islam, MD, FRCPC Lawson Health Research Institute Robarts research Institute The University
More informationMPI Overview. Artifacts and Pitfalls in MPI. Acquisition and Processing. Peeyush Bhargava MD, MBA
Artifacts and Pitfalls in MPI MPI Overview Peeyush Bhargava MD, MBA www.nuclearmd.com ~ 40% of all Nuclear Medicine Procedures ~ 9 million procedures every year in US >95% are SPECT,
More informationOPTIMIZATION OF Rb-82 PET ACQUISITION AND RECONSTRUCTION PROTOCOLS FOR MYOCARDIAL PERFUSION DEFECT DETECTION
2008 IEEE Nuclear Science Symposium Conference Record M10-44 OPTIMIZATION OF Rb-82 PET ACQUISITION AND RECONSTRUCTION PROTOCOLS FOR MYOCARDIAL PERFUSION DEFECT DETECTION ling Tang, Member, IEEE, Arman
More informationPhoton Attenuation Correction in Misregistered Cardiac PET/CT
Photon Attenuation Correction in Misregistered Cardiac PET/CT A. Martinez-Möller 1,2, N. Navab 2, M. Schwaiger 1, S. G. Nekolla 1 1 Nuklearmedizinische Klinik der TU München 2 Computer Assisted Medical
More informationCT Myocardial Perfusion: Is there Added Value to Coronary CT?
CT Myocardial Perfusion: Is there Added Value to Coronary CT? U. Joseph Schoepf, MD, FAHA, FSCBT MR, FSCCT Professor of Radiology, Medicine, and Pediatrics Director of Cardiovascular Imaging Disclosures
More informationThe Status and Future of PET Myocardial Blood Flow Quantification Software
Annals of Nuclear Cardiology Vol. 2 No. 1 106-110 FOCUS ISSUE: MBF QUANTIFICATION REVIEW ARTICLE The Status and Future of PET Myocardial Blood Flow Quantification Software Sergey V. Nesterov, MD, PhD,
More informationNIH Public Access Author Manuscript Mol Imaging Biol. Author manuscript; available in PMC 2011 April 1.
NIH Public Access Author Manuscript Published in final edited form as: Mol Imaging Biol. 2011 April ; 13(2): 342 347. doi:10.1007/s11307-010-0347-4. Image-Derived Input Function from Cardiac Gated Maximum
More informationOld and new insights into viability:perfusion and Perfusion Reserve
Old and new insights into viability:perfusion and Perfusion Reserve R.Senior Professor of Clinical Cardiology Consultant Cardiologist and Director of Echo,Royal Brompton Hospital,London and Northwick Park
More informationSung A Chang Department of Internal Medicine, Division of Cardiology, Sungkyunkwan University School of Medicine, Samsung Medical Center
CMR Perfusion and Viability A STICH Out of Time? Sung A Chang Department of Internal Medicine, Division of Cardiology, Sungkyunkwan University School of Medicine, Samsung Medical Center Can Imaging Improve
More informationASNC/SNMMI POSITION STATEMENT
ASNC ASNC/SNMMI POSITION STATEMENT Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC Writing Group Venkatesh L. Murthy (cochair)*
More informationHybrid imaging of the heart
Pärnu (Estonia) Friday, October 10, 2014 8:00-8:30 a.m Hybrid imaging of the heart María José García Velloso Servicio de Medicina Nuclear Clínica Universidad de Navarra mjgarciave@unav.es Hibrid imaging
More informationSPECT TRACERS Tl-201, Tc-99m Sestamibi, Tc-99m Tetrofosmin
SPECT TRACERS Tl-201, Tc-99m Sestamibi, Tc-99m Tetrofosmin Elmer Jasper B. Llanes, M.D. Nuclear Cardiology St. Luke s Medical Center Outline Ideal Physiologic Characteristics of MPI radioactive tracers
More informationIntegrated PET/CT systems State of the art and Clinical Applications
Integrated PET/CT systems State of the art and Clinical Applications V. Bettinardi Nuclear Medicine Dep. Scientific Institute San Raffaele Hospital Milan Italy The announcement of a new Diagnostic Imaging
More informationIntegrated Report Generation for Myocardial Perfusion SPECT: Efficiency Comparison to Report Dictation
Integrated Report Generation for Myocardial Perfusion SPECT: Efficiency Comparison to Report Dictation C Bui, EP Ficaro, JN Kritzman, G Wu, JR Corbett University of Michigan Health System, Ann Arbor, MI
More informationGender differences in CT calcium scoring: A phantom study
Gender differences in CT calcium scoring: A phantom study Nicholas Petrick, Qin Li, Benjamin Berman, Marios A Gavrielides, Rongping Zeng, Berkman Sahiner CDRH/OSEL/DIDSR U.S. Food and Drug Administration
More informationMyocardial viability testing. What we knew and what is new
Myocardial viability testing. What we knew and what is new Dr B K S Sastry, MD, DM. CARE Hospitals, Hyderabad What is Viability Viability Dysfunctional myocardium subtended by diseased coronary arteries
More informationCARDIAC PET PERFUSION IMAGING with RUBIDIUM-82
CARDIAC PET PERFUSION IMAGING with RUBIDIUM-82 Pr Denis AGOSTINI Président du Groupe de Cardiologie Nucléaire et IRM CHU Caen Bordeaux 2006 Cardiac Perfusion-Metabolism Mismatch with PET Cumulative Survival
More informationRESEARCH ARTICLE. Image-Derived Input Function from Cardiac Gated Maximum a Posteriori Reconstructed PET Images in Mice
B Academy of Molecular Imaging and Society for Molecular Imaging, 2010 Published Online: 3 June 2010 Mol Imaging Biol (2011) 13:342Y347 DOI: 10.1007/s11307-010-0347-4 RESEARCH ARTICLE Image-Derived Input
More informationPET-MRI in Cardiac Imaging: Initial Experience
PET-MRI in Cardiac Imaging: Initial Experience Mallinckrodt Institute of Radiology Washington University School of Medicine Pamela K. Woodard, M.D. Professor of Radiology and Biomedical Engineering Head,
More informationJe bénéficie régulièrement de fonds privés, dans le cadre de projets de recherche ou d activités de formation.
Je bénéficie régulièrement de fonds privés, dans le cadre de projets de recherche ou d activités de formation. Ces fonds proviennent essentiellement d industriels travaillant dans les domaines de l imagerie
More informationState-of-the-Art SPECT/CT: Cardiac Imaging
State-of-the-Art SPECT/CT: Cardiac Imaging Ernest V Garcia*, PhD Endowed Professor in Cardiac Imaging Director, Nuclear Cardiology R&D Laboratory Disclosure: Dr. Garcia receives royalties from the sale
More informationCT Perfusion. U. Joseph Schoepf, MD, FAHA, FSCBT MR, FSCCT Professor of Radiology, Medicine, and Pediatrics Director of Cardiovascular Imaging
CT Perfusion U. Joseph Schoepf, MD, FAHA, FSCBT MR, FSCCT Professor of Radiology, Medicine, and Pediatrics Director of Cardiovascular Imaging Disclosures Consultant for / research support from Bayer Bracco
More informationCARDIAC MRI. Cardiovascular Disease. Cardiovascular Disease. Cardiovascular Disease. Overview
CARDIAC MRI Dr Yang Faridah A. Aziz Department of Biomedical Imaging University of Malaya Medical Centre Cardiovascular Disease Diseases of the circulatory system, also called cardiovascular disease (CVD),
More informationSPECT-CT: Τι πρέπει να γνωρίζει ο Καρδιολόγος
SPECT-CT: Τι πρέπει να γνωρίζει ο Καρδιολόγος Δρ Αναστασία Κίτσιου Διευθύντρια, Καρδιολογική Κλινική, Σισμανόγλειο ΓΝΑ Chair, Education Committee, Section on Nuclear Cardiology & Cardiac CT, EACVI, ESC
More informationCombining Coronary Artery Calcium Scanning with SPECT/PET Myocardial Perfusion Imaging
Combining Coronary Artery Calcium Scanning with SPECT/PET Myocardial Perfusion Imaging Daniel S. Berman, MD Director, Cardiac Imaging Cedars-Sinai Heart Institute Professor of Medicine and Imaging Cedars-Sinai
More informationAppearances can be deceiving.
Appearances can be deceiving. Toscano, W; Wragg, A; Rossi, A; Pugliese, F 2015 The Author(s) For additional information about this publication click this link. http://qmro.qmul.ac.uk/xmlui/handle/123456789/12632
More informationEuropean Journal of Hybrid Imaging. Opstal TSJ 1,3*, Knol RJJ 1,2, Cornel JH 2,3, Wondergem M 1,2 and van der Zant FM 1,2
TSJ et al. European Journal of Hybrid Imaging (2018) 2:11 https://doi.org/10.1186/s41824-018-0029-z European Journal of Hybrid Imaging ORIGINAL ARTICLE Open Access Myocardial blood flow and myocardial
More informationDetection and Assessment of MI: Use of Imaging Methods. Robert O. Bonow, M.D.
Detection and Assessment of MI: Use of Imaging Methods Robert O. Bonow, M.D. Detection and Assessment of MI: Use of Imaging Methods Robert O. Bonow, M.D. No Relationships to Disclose Expert Consensus Document
More informationDual Energy CT of the Heart: Perfusion and Beyond
Dual Energy CT of the Heart: Perfusion and Beyond U. Joseph Schoepf, MD, FAHA, FSCBT MR, FSCCT Professor of Radiology, Medicine, and Pediatrics Director of Cardiovascular Imaging Disclosures Consultant
More informationForm 4: Coronary Evaluation
Form : Coronary Evaluation Print this Form t Started Date of Coronary Evaluation Coronary Evaluation Indication for Coronary Evaluation Check only one. Angio NOT DONE: n invasive test performed Followup
More informationAlignment of Cardiac Structures in [15O]H2O Perfusion PET Studies
Tampere University of Technology Alignment of Cardiac Structures in [15O]H2O Perfusion PET Studies Citation Juslin, A. (2007). Alignment of Cardiac Structures in [15O]H2O Perfusion PET Studies. (Tampere
More informationCardiovascular Imaging
Cardiovascular Imaging Cardiovascular Imaging Cardio and Vascular Imaging Vascularization / Angiogenesis Cardiovascular Imaging metabolic imaging of the heart myocardial perfusion imaging Cardiac CT Vascularization
More informationHow to Evaluate Microvascular Function and Angina. Myeong-Ho Yoon Ajou University Hospital
How to Evaluate Microvascular Function and Angina Myeong-Ho Yoon Ajou University Hospital Angina without Coronary Artery Disease (CAD) Prevalence: 20-30% going c-angiography, with a higher prevalence (almost
More informationStress only Perfusion Imaging
European Society of Cardiology Annual meeting, 2010, Stockholm, Sweden Stress only Perfusion Imaging Oliver Gaemperli, MD Cardiovascular Center, University Hospital Zurich, Switzerland Male patient, 48
More informationAbnormal, Autoquant Adenosine Myocardial Perfusion Heart Imaging. ID: GOLD Date: Age: 46 Sex: M John Doe Phone (310)
Background: Reason: preoperative assessment of CAD, Shortness of Breath Symptom: atypical chest pain Risk factors: hypertension Under influence: a beta blocker Medications: digoxin Height: 66 in. Weight:
More informationCurrent Guidelines for Diagnosis of AMI Chest pain ST change on EKG Cardiac Enzymes
Noninvasive Cardiac Imaging in Myocardial Infarction Sangchol Lee Sungkyunkwan University Samsung Medical Center Current Guidelines for Diagnosis of AMI Chest pain ST change on EKG Cardiac Enzymes Do We
More informationPET for the Evaluation of Myocardial Viability
PET for the Evaluation of Myocardial Viability Myocardial viability assessment is an important part of cardiac PET to assist physicians to decide upon the best surgical or medical procedures. F-18 FDG
More informationPositron emission tomography and molecular imaging
Positron emission tomography and molecular imaging EHH, May, 2010 Juhani Knuuti Turku PET Centre University of Turku Turku, Finland Juhani.knuuti@utu.fi PET Imaging in Medicine MRI CT MRI PET US SPET MEG
More informationIMR in acute STEMI and clinical outcomes
IMR in acute STEMI and clinical outcomes Professor Colin Berry Golden Jubilee National Hospital, University of Glasgow. ETP Coronary Physiology 24 April 2015 Disclosures Speaker - Shire Pharmaceuticals,
More informationPET: quantification of perfusion and beyond
PET: quantification of perfusion and beyond Juhani Knuuti Turku PET Centre University of Turku Turku, Finland Juhani.knuuti@utu.fi 27.8.2012 1 Disclosure: Juhani Knuuti, M.D. Juhani Knuuti, M.D. has financial
More informationForm 4: Coronary Evaluation
Patient Details Hidden Show Show/Hide Annotations Form : Coronary Evaluation Print this Form t Started Date of Coronary Evaluation Coronary Evaluation Indication for Coronary Evaluation Check only one.
More informationValidation of CT Perfusion Imaging Against Invasive Angiography and FFR on a 320-MDCT Scanner
Validation of CT Perfusion Imaging Against Invasive Angiography and FFR on a 320-MDCT Scanner Zhen Qian, Gustavo Vasquez, Sarah Rinehart, Parag Joshi, Eric Krivitsky, Anna Kalynych, Dimitri Karmpaliotis,
More information3D-stress echocardiography Bernard Cosyns, MD, PhD
3D-stress echocardiography Bernard Cosyns, MD, PhD No Disclosure The Pro-Technology bias Sicari et al. Cardiovascular Ultrasound 2006, 4:11 Overview 2D stress echocardiography: main limitations 3D echocardiography:
More informationMOLINA HEALTHCARE OF MICHIGAN PRIOR AUTHORIZATION / PRE-SERVICE REVIEW GUIDE IMAGING CODES REQUIRING PRIOR AUTHORIZATION EFFECTIVE 1/1/2014
70336 MRI MRI, temporomandibular joint(s) 70450 CT/CTA CT, head or brain; without contrast material 70460 CT/CTA CT, head or brain; with contrast material(s) 70470 CT/CTA CT, head or brain; without contrast
More informationCase-Based Pitfalls of SPECT and PET: Recognizing and Working with Artifacts
2:20 PM Friday WORKSHOP V Case-Based Pitfalls of SPECT and PET: Recognizing and Working with Artifacts Sean W. Hayes, MD Associate Clinical Professor of Medicine UCLA School of Medicine Cedars-Sinai Heart
More informationBiases affecting tumor uptake measurements in FDG-PET
Biases affecting tumor uptake measurements in FDG-PET M. Soret, C. Riddell, S. Hapdey, and I. Buvat Abstract-- The influence of tumor diameter, tumor-tobackground activity ratio, attenuation, spatial resolution,
More informationNew Challenges in Nuclear Cardiology Practice
New Challenges in Nuclear Cardiology Practice Brian G. Abbott, MD, FACC, FASNC, FAHA President, ASNC 2016 Associate Professor of Medicine Warren Alpert Medical School of Brown University Director, Cardiovascular
More informationHybrid Imaging Improving Nuclear Cardiology Practice
Lippincott Williams & Wilkins, - Nuclear Medicine teaching File, 2009 Hybrid Imaging Improving Nuclear Cardiology Practice João V. Vitola, MD, PhD Cardiologist and Nuclear Medicine Physician Quanta Diagnostico
More informationCT or PET/CT for coronary artery disease
CT or PET/CT for coronary artery disease Rotterdam 2012 Juhani Knuuti, MD, PhD, FESC Turku PET Centre University of Turku Turku, Finland Juhani.knuuti@utu.fi Turku PET Centre University of Turku Åbo Akademi
More informationConflict of Interest Disclosure
Challenges and Opportunities for SPECT & PET in 2013: Implementing Latest Acquisition and Processing Protocols Timothy M. Bateman M.D. Co-Director, Cardiovascular Radiologic Imaging Mid America Heart Institute
More informationDiffuse Disease and Serial Stenoses
Diffuse Disease and Serial Stenoses Bernard De Bruyne Cardiovascular Center Aalst Belgium Atherosclerosis is a Diffuse Disease Serial Stenoses A B P a P m P d When A is isolated, hyperemic flow through
More informationFundamentals of Nuclear Cardiology. Terrence Ruddy, MD, FRCPC, FACC
Fundamentals of Nuclear Cardiology Terrence Ruddy, MD, FRCPC, FACC Objectives To understand the Principles of Nuclear Cardiac Imaging Radiotracers Image acquisition and processing Stress protocols To appreciate
More informationRubidium-82 myocardial perfusion PET/CT
Rubidium- myocardial perfusion PET/CT A.M. Scholtens, MD 1 ; P.C. Barneveld, MD 2 Departments of Nuclear Medicine of 1 Meander Medical Center, Amersfoort, the Netherlands, and 2 Jeroen Bosch Hospital,
More informationFeasibility of a New C-arm angiography (DYNA-CT) based three-dimensional algorithm in combination with myocardial perfusion assessment
Feasibility of a New C-arm angiography (DYNA-CT) based three-dimensional algorithm in combination with myocardial perfusion assessment H. Rittger*, A.M.Sinha, J. Rieber±, G. Lauritsch+, J. Brachmann *Universitätsklinik
More informationControl of Myocardial Blood Flow
Control of Myocardial Blood Flow Blood goes where it is needed John Hunter, 1794 Cited by Dunker DJ and Bache RJ Physiol Rev, 2008 Bernard De Bruyne, MD, PhD Cardiovascular Center Aalst OLV-Clinic Aalst,
More informationHabib Zaidi Rene Nkoulou Sarah Bond Aylin Baskin Thomas Schindler Osman Ratib Jerome Declerck
Int J Cardiovasc Imaging (2013) 29:1351 1360 DOI 10.1007/s10554-013-0207-9 ORIGINAL PAPER Computed tomography calcium score scan for attenuation correction of N-13 ammonia cardiac positron emission tomography:
More informationForm 4: Coronary Evaluation
Page of 7 Patient Details Hidden Show Show/Hide Annotations Stickies: Toggle All Toggle Open Toggle Resolved Form : Coronary Evaluation Print this Form t Started Date of Coronary Evaluation Coronary Evaluation
More informationDebate Should we use FFR? I will say NO.
Debate Should we use FFR? I will say NO. Hyeon-Cheol Gwon Cardiac and Vascular Center Samsung Medical Center Sungkyunkwan University School of Medicine Dr. Hyeon-Cheol Gwon Research fund from Abbott Korea
More informationDiffuse Disease and Serial Stenoses. Bernard De Bruyne Cardiovascular Center Aalst Belgium
Diffuse Disease and Serial Stenoses Bernard De Bruyne Cardiovascular Center Aalst Belgium Atherosclerosis is a Diffuse Disease Serial Stenoses A B P a P m P d When A is isolated, hyperemic flow through
More informationFractional Flow Reserve and instantaneous wave -free Ratio. Λάμπρος Κ. Μόσιαλος Επεμβατικός Καρδιολόγος ΓΝ Παπαγεωργίου
Fractional Flow Reserve and instantaneous wave -free Ratio Λάμπρος Κ. Μόσιαλος Επεμβατικός Καρδιολόγος ΓΝ Παπαγεωργίου DISCLOSURES There are no financial conflicts of interest relevant to this presentation
More informationHigh Speed Myocardial Perfusion SPECT: Validation of Quantitative Analysis and use in Low Dose Stress only Protocol
High Speed Myocardial Perfusion SPECT: Validation of Quantitative Analysis and use in Low Dose Stress only Protocol Tali Sharir 1, Marina Pinskiy 1, Vitaly Prochorov 1, Andrzej Bojko 1, Arik Rochman 1,
More informationPrevious MI with no intervention
Previous MI with no intervention F. Mut, M. Beretta Nuclear Medicine Service, Asociacion Española Montevideo, Uruguay Clinical history Woman 68 y.o. Recent acute MI (3 weeks) with no intervention. Discharged
More information05/02/ CPT Preauthorization Groupings Effective May 2, Computerized Tomography (CT) Abdomen 6. CPT Description SEGR CT01
Computerized Tomography (CT) 6 & 101 5 Upper Extremity 11 Lower Extremity 12 Head 3 Orbit 1 Sinus 2 Neck 4 7 Cervical Spine 8 Thoracic Spine 9 Lumbar Spine 10 Colon 13 CPT Preauthorization Groupings CPT
More informationMINIMIZING RADIATION EXPOSURE
MINIMIZING RADIATION EXPOSURE FROM MYOCARDIAL PERFUSION IMAGING ASNC 2017 Choosing Wisely Challenge Debra Mahlum, Maureen Vander Kooy, Steven Port, M.D. Aurora Cardiovascular Services Disclosure Information
More informationImaging congestive heart failure: role of coronary computed tomography angiography (CCTA)
Imaging congestive heart failure: role of coronary computed tomography angiography (CCTA) Gianluca Pontone, MD, PhD, FESC, FSCCT Director of MR Unit Deputy Director of Cardiovascul CT Unit Clinical Cardiology
More informationAdvantages of PET Myocardial Imaging
Advantages of PET Myocardial Imaging Legal Disclaimers These materials were prepared in good faith by MITA as a service to the profession and are believed to be reliable based on current scientific literature.
More information2019 Qualified Clinical Data Registry (QCDR) Performance Measures
2019 Qualified Clinical Data Registry (QCDR) Performance Measures Description: This document contains the 18 performance measures approved by CMS for inclusion in the 2019 Qualified Clinical Data Registry
More informationMechanisms and role of contrast echocardiography
Mechanisms and role of contrast echocardiography Seol Sang-Hoon Inje University College of Medicine, Haeundae Paik Hospital, Busan, Korea Physical Principles of Contrast Ultrasound Contrast echocardiography
More informationStable Angina: Indication for revascularization and best medical therapy
Stable Angina: Indication for revascularization and best medical therapy Cardiology Basics and Updated Guideline 2018 Chang-Hwan Yoon, MD/PhD Cardiovascular Center, Department of Internal Medicine Bundang
More informationHybrid cardiac imaging Advantages, limitations, clinical scenarios and perspectives for the future
Hybrid cardiac imaging Advantages, limitations, clinical scenarios and perspectives for the future Prof. Juhani Knuuti, MD, FESC Turku, Finland Disclosure: Juhani Knuuti, M.D. Juhani Knuuti, M.D. has financial
More informationForm 4: Coronary Evaluation
Page of 8 Patient Details Hidden Show Show/Hide Annotations Stickies: Toggle All Toggle Open Toggle Resolved Form : Coronary Evaluation Toggle Question Year/Info Print this Form t Started Date of Coronary
More informationI have no financial disclosures
Manpreet Singh MD I have no financial disclosures Exercise Treadmill Bicycle Functional capacity assessment Well validated prognostic value Ischemic assessment ECG changes ST segments Arrhythmias Hemodynamic
More informationOn the feasibility of speckle reduction in echocardiography using strain compounding
Title On the feasibility of speckle reduction in echocardiography using strain compounding Author(s) Guo, Y; Lee, W Citation The 2014 IEEE International Ultrasonics Symposium (IUS 2014), Chicago, IL.,
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
PET Scanning: Cardiac Applications Page 1 of 31 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Positron Emission Tomography (PET) Scanning: Cardiac Applications
More informationAustin Radiological Association Ga-68 NETSPOT (Ga-68 dotatate)
Austin Radiological Association Ga-68 NETSPOT (Ga-68 dotatate) Overview Ga-68 dotatate binds to somatostatin receptors, with highest affinity for subtype 2 receptors (sstr2). It binds to cells that express
More informationPerfusion CMR: State of the Art
Perfusion CMR: State of the Art Dudley Pennell MD FRCP FACC FESC Director CMR Unit, Royal Brompton Hospital Professor of Cardiology National Heart & Lung Institute, Imperial College Outline Current status
More information@02-126_Coronary_calcification.ppt. Professor Molecular and Medical Pharmacology
Assessment of Myocardial Viability Jamshid Maddahi, M.D., FACC, FASNC Professor Molecular and Medical Pharmacology (Nuclear Medicine) and Medicine (Cardiology) David Geffen School of Medicine at UCLA Director,
More informationModifi ed CT perfusion contrast injection protocols for improved CBF quantifi cation with lower temporal sampling
Investigations and research Modifi ed CT perfusion contrast injection protocols for improved CBF quantifi cation with lower temporal sampling J. Wang Z. Ying V. Yao L. Ciancibello S. Premraj S. Pohlman
More information